IceCure Medical (ICCM) Enterprise Value (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Enterprise Value data on file, last reported at -$8.1 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 34.35% year-over-year to -$8.1 million in Q1 2026; TTM through Mar 2026 was -$8.1 million, a 34.35% decrease from a year earlier, with the FY2025 full-year figure at -$8.9 million, down 17.62% from the prior year.
• Enterprise Value for Q1 2026 stood at -$8.1 million, up from -$8.9 million in the prior quarter.
• Over the last five years, Enterprise Value for ICCM reached as high as -$4.1 million in Q3 2023 and fell as low as -$39.0 billion in Q4 2024.
• Historically, Enterprise Value has averaged -$2.3 billion across 5 years, with a median of -$10.7 million in 2024.
• Across the five-year window, Enterprise Value slumped 352458.31% in 2024 and surged 99.98% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$319.7 million in 2022, then soared by 96.54% to -$11.1 million in 2023, then slumped by 352458.31% to -$39.0 billion in 2024, then jumped by 99.98% to -$8.9 million in 2025, then increased by 8.79% to -$8.1 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$8.1 million in Q1 2026, -$8.9 million in Q4 2025, and -$10.0 million in Q3 2025.